Results 21 to 30 of about 577 (167)
Validation of PROMIS Profile‐29 in adults with hemophilia in the Netherlands
Journal of Thrombosis and Haemostasis, Volume 19, Issue 11, Page 2687-2701, November 2021., 2021 Abstract Background The Patient‐Reported Outcomes Measurement Information System (PROMIS) Profile‐29 questionnaire is widely used worldwide, but it has not yet been validated in the Netherlands, nor in persons with hemophilia. Objective To validate the Dutch‐Flemish version of the PROMIS‐29 Profile v2.01 in adults with hemophilia.
Erna C. van Balen +16 more
wiley +1 more source
Casos Radiológicos. Historia Clínica
ARS Medica, 2016 Sin ...
Cristián García Bruce +1 more
doaj +1 more source
Hematology, Transfusion and Cell Therapy, 2021 Introdução: A hemofilia é uma doença genética hereditária ligada ao cromossomo X, sendo mais frequente em homens do que em mulheres. As manifestações clínicas da hemofilia advêm de sangramentos internos, podendo se agravar para uma hemorragia como ...
ABO Araújo +4 more
doaj +1 more source
Jornal de Assistência Farmacêutica e Farmacoeconomia, 2022 Introdução: Para a tomada de decisão, a Avaliação de Tecnologias em Saúde (ATS) inclui a análise baseada em evidências, levando em consideração várias dimensões não só clínicas e econômicas. No Brasil, a Comissão Nacional de Incorporação de Tecnologias
Thales Brendon Castano Silva +1 more
doaj +1 more source
Medisan, 2022 Introduction: The hemophilia is a disease of genetic origin, linked to chromosome X that affects the natural capacity of the blood to form a clot, due to the absence, decrease or a defective operation of the factors VIII and IX, hence the types A and B,
Haron Fernández Alvarez
doaj
Sari Pediatri, 2019 Latar belakang. Gejala perdarahan pada hemofilia A bergantung pada kadar faktor VIII, namun pada kadar faktor koagulasi yang sama dapat terjadi perbedaan karakteristik dan luaran klinis. Tujuan.
Novie Amelia Chozie +2 more
doaj +1 more source
Faktor Risiko Non-genetik Inhibitor Faktor VIII pada Pasien Hemofilia A
Sari Pediatri, 2016 Latar belakang. Terbentuknya inhibitor atau antibodi terhadap FVIII pada pasien hemofilia A menyebabkan FVIII eksogen yang diberikan tidak dapat berfungsi. Penyebab bersifat multifaktorial terdiri atas faktor genetik dan lingkungan.
Ahmad Saifudin +2 more
doaj +1 more source
Medicinus, 2018 Hemophilia A and B are X-linked recessive diseases that are caused by gene mutations in factors VIII adan IX of the blood clotting cycle. Hemophilia C is an autosomal recessive disease caused by a mutation in factor XI, and acquired hemophilia is largely is an autoimmune process.
Michael Susanto, Andree Kurniawan
openaire +2 more sources
Atención dental en pacientes diagnosticados con hemofilia grave a con presencia de inhibidores
Revista Científica Especialidades Odontológicas UG, 2020 Enfermedad genética recesiva, cuyo gen está asociado con el cromosoma sexual X, caracterizada por la deficiencia de algunos factores de coagulación. La hemofilia A se clasifica como deficiencia de factor FVIII, hemofilia B (FIX), hemofilia C (FXI), que ...
Andrea Caiza Rennella +3 more
doaj +1 more source
Human Mutation, Volume 41, Issue 12, Page 2058-2072, December 2020., 2020 Abstract In hemophilia A and B, analysis of the F8 and F9 gene variants enables carrier and prenatal diagnosis and prediction of risk for the development of inhibitors. The PedNet Registry collects clinical, genetic, and phenotypic data prospectively on more than 2000 children with hemophilia.
Nadine G. Andersson +10 more
wiley +1 more source